Search for: "AVENTIS PHARMACEUTICALS, INC.,"
Results 101 - 120
of 219
Sort by Relevance
|
Sort by Date
19 Oct 2010, 8:05 pm
On the same day as FDA's decision, FDA approved a generic Ambien CR® 6.25 mg tablet (tentative approval for 12 mg tablet) filed by Actavis and tentative approvals for generic Ambien CR® 6.25 mg and 12 mg tablets filed by Synthon Pharmaceuticals, Inc. [read post]
6 Oct 2010, 4:22 am
Sandoz, Inc. et al (Docket Report) [read post]
24 Sep 2010, 1:15 pm
Ortho-McNeil Pharmaceutical, Inc. v. [read post]
15 Sep 2010, 2:15 am
Watson Pharmaceuticals, Inc., D2010-0800 (WIPO August 31, 2010). [read post]
2 Sep 2010, 10:51 am
Ortho-McNeil Pharmaceutical, Inc. v. [read post]
31 Aug 2010, 10:01 pm
Apotex Inc. et al (Docket Report) Lovenox (Enoxaparin) – US: DC District Court denies preliminary injunction in generic Lovenox case; Is the juice worth the squeeze for Sanofi to appeal? [read post]
27 Aug 2010, 2:41 pm
Ortho Pharmaceutical Corp., 209 Cal. [read post]
25 Aug 2010, 12:37 am
Watson Pharma, Inc. et al. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
5 Aug 2010, 2:08 pm
Wyeth Laboratories, Inc., 533 N.E.2d 748 (Ohio 1988) (the Ohio Supreme Court rejecting the theory). [read post]
23 Jul 2010, 10:55 am
Karst – Earlier today, FDA issued its long-awaited response (45 pages) to a February 2003 citizen petition submitted to the Agency on behalf of Aventis Pharmaceuticals, Inc. [read post]
1 Jul 2010, 1:32 pm
Novartis Pfizer Sanofi-Aventis Takeda Pharmaceuticals [read post]
23 Jun 2010, 10:28 pm
Anchen Pharmaceuticals, Inc. [read post]
16 Jun 2010, 3:02 pm
Zydus Pharmaceuticals USA, Inc. et al. [read post]
16 Jun 2010, 2:04 am
Pharmaceuticals (Sanofi-Aventis), banks and finance (Citigroup, Inc., MasterCard International Incorporated) , fashion (Christian Dior Couture), retail (Harrods Limited, Burberry Limited), hotels and travel (Sheraton International Inc.), automobiles (Bayerische Motoren Werke AG (BMW AG)) and toy manufacturers (LEGO Juris A/S) are frequent targets. [read post]
10 Jun 2010, 3:58 am
Par Pharmaceutical, Inc. [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva, stipulates… [read post]
28 May 2010, 11:51 pm
Aventis Pharmaceuticals, Inc., 468 F.3d 1366, 1374-75 (Fed. [read post]
21 May 2010, 2:32 am
Two recent examples of disclaimers bolstering bad faith are Sanofi-Aventis, Aventis Pharma SA, Aventis Pharmaceuticals Inc. v. [read post]
5 May 2010, 4:46 am
Cyclacel Pharmaceuticals Inc. [read post]
